CAS 316146-57-3

3-nitro-N-(4-phenoxyphenyl)-benzamide

Description:

3-Nitro-N-(4-phenoxyphenyl)-benzamide is an organic compound characterized by its complex structure, which includes a benzamide core substituted with a nitro group and a phenoxyphenyl moiety. The presence of the nitro group typically imparts certain electronic properties, making the compound potentially useful in various chemical reactions or applications, such as in pharmaceuticals or as a synthetic intermediate. The phenoxy group contributes to the compound's hydrophobic characteristics, which can influence its solubility and interaction with biological systems. This compound may exhibit specific biological activities, making it of interest in medicinal chemistry. Its molecular structure suggests potential for hydrogen bonding due to the amide functional group, which can affect its stability and reactivity. Additionally, the compound's properties, such as melting point, boiling point, and solubility, would depend on the specific arrangement of its atoms and the presence of functional groups. Overall, 3-nitro-N-(4-phenoxyphenyl)-benzamide represents a class of compounds that can be explored for various chemical and biological applications.

Formula: C₁₉H₁₄N₂O₄

Synonyms:

• Benzamide, 3-nitro-N-(4-phenoxyphenyl)-
• 3-nitro-N-(4-phenoxyphenyl)-benzamide
• ICA-105574

ICA-105574

CAS: 316146-57-3

ICA-105574

Purity: ≥98%

Molecular weight: 334.33g/mol

Ref: 54-BUP08379

ICA-105574

CAS: 316146-57-3

ICA-105574 activates hERG, enhancing peak current and shortening action potential, while modulating activation kinetics.

Formula: C₁₉H₁₄N₂O₄

Purity: 98.89%

Color and Shape: Solid

Molecular weight: 334.33

Ref: TM-T9009

ICA-105574

CAS: 316146-57-3

ICA-105574 is an anticancer drug that works by inhibiting certain kinases in cancer cells. It has been shown to be effective against various types of human tumors, including those found in Chinese patients. ICA-105574 is a protein kinase inhibitor that induces apoptosis, which is the programmed death of cancer cells. It has been found to bind specifically to D-xylose in urine and inhibit the activity of kinases involved in tumor growth and survival. This drug has great potential as a targeted therapy for cancer treatment due to its ability to selectively target cancer cells while sparing healthy ones. With its potent anticancer properties, ICA-105574 represents a promising new class of kinase inhibitors for the treatment of various types of cancer.

Formula: C₁₉H₁₄N₂O₄

Purity: Min. 95%

Molecular weight: 334.3 g/mol

Ref: 3D-RMA14657